O. Eizenberg et al., LINEAR DIMERIC INTERLEUKIN-2 OBTAINED BY THE USE OF A DEFECTIVE HERPES-SIMPLEX VIRAL VECTOR - CONFORMATION-ACTIVITY RELATIONSHIP, Molecular brain research, 26(1-2), 1994, pp. 156-162
An interleukin-2 dimer, produced enzymatically by a nerve-derived tran
sglutaminase in vitro, is cytotoxic to oligodendrocytes, unlike the im
mune-derived monomeric interleukin-2. The abject of this study was to
establish a way to produce a dimer of interleukin-2 in quantities, by
means of genetic engineering, and to confirm that the structure of the
resulting molecule is critical for its function. A defective herpes s
implex virus vector was utilized for overproduction of a dimeric inter
leukin-2. The resulting linear dimer, which is a translational product
, differs from the enzymatically produced dimer, which is a posttransl
ational modification of interleukin-2. The linear dimer, while retaini
ng the known interleukin-2 activity of monomeric interleukin-2 with re
spect to mitogenicity on T cells, was not cytotoxic to oligodendrocyte
s. This finding suggests that the lack of cytotoxicity of the linear d
imeric interleukin-2 is not caused by a loss of activity during its pr
eparation but is related to its conformational structure, which eviden
tly does not meet the requirements for cytotoxicity. This study opens
the way to the design at the transcriptional level of modified protein
s and their efficient production, provided that the new transcript enc
odes for the desired modification in the protein at the appropriate si
tes.